Perigon Wealth Management »

Humacyte shares owned by Perigon Wealth Management

Quarter-by-quarter ownership of Humacyte (HUMA) shares owned by Perigon Wealth Management from 13F filings

Historical chart of Perigon Wealth Management investment in Humacyte

Tip: Access up to 7 years of quarterly data

All positions including Humacyte held by Perigon Wealth Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Humacyte by Perigon Wealth Management

Quarter filed Position value Share count Share price at filing
2026-06-30 $9.1k 12k 0.78

More positions owned by Perigon Wealth Management

NVIDIA Corporation (NVDA)
Apple (AAPL)
Vanguard Index Fds S&p 500 Etf Shs (VOO)
Invesco Qqq Tr Unit Ser 1 (QQQ)
Ishares Tr Core S&p500 Etf (IVV)
Amazon (AMZN)
Alphabet Cap Stk Cl C (GOOG)
Vanguard Scottsdale Fds Inter Term Treas (VGIT)
Alphabet Cap Stk Cl A (GOOGL)
Gmo Etf Trust Us Quality Etf (QLTY)
Microsoft Corporation (MSFT)
Dimensional Etf Trust Us Cor Equ 2 Etf (DFAC)
State Str Spdr S&p 500 Etf T Tr Unit (SPY)
J P Morgan Exchange Traded F Betabuildrs Us (BBUS)
Broadcom (AVGO)

View all positions for Perigon Wealth Management

Top funds holding Humacyte

Vanguard Capital Management
Antipodes Partners
Alyeska Investment Group
Davidson Kempner Capital Management
BlackRock
Dr. Jeffrey R. Jay, M.D.
State Street Corporation
Susquehanna International
UBS Group
AQR Capital Management
Geode Capital Management
Millennium Management
Citadel Advisors
Charles Schwab Investment Management
Sixth Street Partners Management Company

View all funds holding Humacyte